Uncategorized

Sales of Olainfarm in October grow by 22%

on 15 lapkričio, 2016 Komentavimas išjungtas įraše Sales of Olainfarm in October grow by 22%

According to preliminary consolidated results of JSC Olainfarm for October 2016, sales of the group have reached 10.18 million euros, which represents an increase by 22% compared to the same period one year ago. The biggest sales increase was achieved in Uzbekistan, where sales grew by 220%. Sales to Russia grew by 94% but sales to Kyrgyzstan grew by 71%. During October, JSC Olainfarm also made significant shipments to The Netherlands, Germany and Georgia. Biggest sales markets during October were Russia, Latvia and Ukraine.

October 2016, consolidated sales Sales, thsnd. EUR Changes to October 2015 Share in total sales
Russia 4 210 94% 41%
Latvia 2 340 9% 23%
Ukraine 1 113 -39% 11%
Belarus 547 -24% 5%
The Netherlands 360 NA 4%
Kazakhstan 340 -4% 3%
Uzbekistan 300 220% 3%
Germany 280 NA 3%
Kyrgyzstan 112 71% 1%
Georgia 98 NA 1%
Other 477 -53% 5%
Total 10 177 22% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. during October 2016 were 1.62 million euros, which represents an increase by 1% compared to the same period one year ago. Sixty-four pharmacies were operating during this period. Sales of Latvian green pharma company Silvanols during October 2016 were 0.53 million euro, which represents an increase by 36% compared to sales this company made during October 2015. During this period, Silvanols Ltd. sold its products to eight European countries and with assistance from JSC Olainfarm also to Russia, Kazakhstan and Azerbaijan. Sales of elastic medical materials producer Tonus Elast Ltd. during October 2016 were 0.87 million euros, the company was making its sales to 16 countries in three continents.

According to preliminary results, in ten months of 2016, consolidated sales of JSC Olainfarm reached 88.69 million euros, which represents an increase by 9% compared to the same period of 2015. The most rapid sales increase during this ten months period was achieved in Uzbekistan, where sales grew by 85%. Sales to Ukraine grew by 25%, sales to Turkmenistan and the UK each grew by 24%. The major sales markets during ten months were Russia, Latvia, Ukraine and Belarus.

10 months of 2016, consolidated sales Sales, thousand EUR Changes to 10 months of 2015 Share in total sales
Russia 27 199 1% 31%
Latvia 21 540 14% 24%
Ukraine 13 263 25% 15%
Belarus 6 862 16% 8%
Kazakhstan 2 364 12% 3%
Uzbekistan 2 080 85% 2%
The Netherlands 1 999 -60% 2%
UK 1 921 23% 2%
Poland 1 098 3% 1%
Turkmenistan 1 067 23% 1%
Other 9 299 22% 10%
Total 88 692 9% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in ten months were 15.5 million euros, which represents an increase by 12% compared to ten months of last year. Sales of Silvanols Ltd. in ten months were 4.21 million euros, which represents an increase by 28% compared to the same period of 2015, when Silvanols’ sales were 3.3 million euros. Silvanols Ltd. made its sales to thirteen European countries and with assistance of JSC Olainfarm also to Albania, Kosovo, Azerbaijan, Kazakhstan, Belarus, Lithuania and Russia. Sales of Tonus Elast Ltd. in five months was 3.53 million euros, its products were sold to 30 countries in four continents.

According to preliminary unconsolidated results, sales of JSC Olainfarm in October 2016 were 8.02 million euros, which represents an increase by 11% compared to the same period of tha last year. The biggest sales increase was achieved in Uzbekistan, where it grew by 220%. Sales to Russia grew by 77%, but sales to Kyrgyzstan grew by 35%. During October 2016, significant shipments were also made to the Netherlands and Germany. The biggest sales markets were Russia, Ukraine, Latvia and Belarus. During October 2016, products of JSC Olainfarm were sold to 22 countries of Europe and Asia.

October 2016, unconsolidated sales Sales, thsnd. EUR Changes to October 2015 Share in total sales
Russia 3 849 77% 48%
Ukraine 1 095 -40% 14%
Latvia 1 088 1% 14%
Belarus 522 -27% 7%
The Netherlands 360 NA 4%
Uzbekistan 300 220% 4%
Germany 279 NA 3%
Kazakhstan 143 -60% 2%
Kyrgyzstan 89 35% 1%
Lithuania 72 3% 1%
Other 221 -75% 3%
Total 8 018 11% 100%

 

According to preliminary unconsolidated results, sales of JSC Olainfarm in ten months of 2016 was 74.09 million euros, which represents an increase by 4% compared to ten months of 2015. The most rapid sales increase during this ten months period was achieved in Uzbekistan, where sales grew by 85%. Sales to Lithuania grew by 25%, Sales to Ukraine grew by 24%, but sales to Turkmenistan grew by 23%. The biggest sales markets of JSC Olainfarm in ten months of 2016 were Russia, Ukraine, Latvia and Belarus. In total during this period, products of JSC Olainfarm were sold to 41 countries in four continents.

10 months of 2016, unconsolidated sales Sales, thousand EUR Changes to 10 months of 2015 Share in total sales
Russia 26 436 -1% 36%
Ukraine 13 126 24% 18%
Latvia 11 005 7% 15%
Belarus 6 815 16% 9%
Uzbekistan 2 080 85% 3%
The Netherlands 1 999 -60% 3%
Kazakhstan 1 870 -11% 3%
UK 1 815 16% 2%
Turkmenistan 1 067 23% 1%
Lithuania 890 25% 1%
Other 6 989 5% 9%
Total 74 092 4% 100%

 

AGM of JSC Olainfarm held on June 7, this year approved operating plan of the Company and the Group, providing that Company’s sales in 2016 will reach 86 million euros, while Group’s sales will reach 100 million euros. According to these preliminary sales numbers, in ten months of 2016 eighty-six percent of planned annual Company’s sales and 89% percent of planned annual Group’s sales have been attained.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

 

 

read more
Sales of Olainfarm in October grow by 22%

Olainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors

on 24 spalio, 2016 Komentavimas išjungtas įraše Olainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors

From October 24 through October 28 Member of the Board and Investor relations officer of JSC Olainfarm Mr. Salvis Lapins will have his third annual road show to update investors about Olainfarm’s performance and near future intentions. Presentations will be organized in capitals of six countries. For the first time road show will also include Warsaw and Copenhagen

„This is the third year when at the end of October we organize road show to meet our investors. We report on what has happened during the year and discuss our vision about our future development. I am delighted that the event is becoming increasingly popular among the investors and that the geography of interest is also expanding, as this year investors from Poland and Denmark have also expressed interest,” says Salvis Lapins, Member of Olainfarm’s Board and company’s Investor Relations Officer.

Meetings are planned on October 24 in Vilnius, October 25 in Warsaw, October 26 in Copenhagen and in Stockholm, October 27 in Helsinki and October 28 in Tallinn. More than 20 meetings have been scheduled so far and during those meetings the enclosed presentation will be distributed: Baltic Sea Region Roadshow Presentation.

 

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Olainfarm Goes on a Road Show to Baltic, Nordic and Polish Investors

Olainfarm’s Sales in September are 8.21 Million Euros

on 17 spalio, 2016 Komentavimas išjungtas įraše Olainfarm’s Sales in September are 8.21 Million Euros

Preliminary consolidated results of JSC Olainfarm for September 2016 show that sales of the company have reached 8.21 million euros, which represents an increase by 2% compared to the same period one year ago. The major sales increase has been achieved in Kazakhstan, where sales grew by 281%. Sales to Tajikistan grew by 188%, but sales to Spain grew by 102%. During September, significant shipments have also been made to the UK and Denmark. Major sales markets during this period were Latvia, Russia, Ukraine, The Netherlands and Belarus.

September 2016, consolidated sales Sales, thsnd. EUR Changes to September 2015 Share in total sales
Latvia 2 418 15% 29%
Russia 2 043 -10% 25%
Ukraine 661 -44% 8%
The Netherlands 549 37% 7%
Belarus 544 15% 7%
Kazakhstan 456 281% 6%
UK 302 NA 4%
Spain 129 102% 2%
Denmark 119 NA 1%
Tajikistan 114 188% 1%
Other 879 -36% 11%
Total 8 214 2% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in September 2016 were 1.6 million euros, which represents an increase by 12% compared to September 2015. Sixty-two pharmacies were operating during this period. Sales of Silvanols Ltd. in September 2016 were 0.63 million euros, which is an increase by 17% compared to its sales in September of last year. Silvanols Ltd. sold its products to four European countries and with the help of JSC Olainfarm also to Russia, Lithuania and Kazakhstan. Sales of Tonus Elast in September were 0.53 million euros, and the company sold its products to 16 countries in three continents.

According to preliminary consolidated numbers for nine months of 2016, sales of JSC Olainfarm have reached 78.51 million euros, which represents an increase by 8% compared to nine months period of 2015. The biggest sales increase in nine months was achieved in Uzbekistan, where sales grew by 72%. Sales to Turkmenistan and Ukraine grew by 38% each and sales to UK grew by 24%. Major sales markets during this period were Russia, Latvia, Ukraine and Belarus.

9 months of 2016, consolidated sales Sales, thsnd. EUR Changes to 9 months of 2015 Share in total sales
Russia 22 989 -7% 29%
Latvia 19 200 15% 24%
Ukraine 12 149 38% 15%
Belarus 6 316 22% 8%
Kazakhstan 2 024 16% 3%
UK 1 891 24% 2%
Uzbekistan 1 780 72% 2%
The Netherlands 1 639 -67% 2%
Turkmenistan 1 067 38% 1%
Lithuania 956 16% 1%
Other 8 496 10% 11%
Total 78 507 8% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in nine months were 13.9 million euros, which is an increase by 14% compared to same period of 2015. Sales of Silvanols Ltd. in nine months of 2016 were 3.68 million euros, which represents an increase by 27% compared to nine months of last year, when Silvanols’ sales were 2.9 million euros. Products of Silvanols Ltd. were sold to eleven European countries and with the help of JSC Olainfarm, also to Albania, Kosovo, Azerbaijan, Kazakhstan, Belarus and Russia. Sales of Tonus Elast Ltd. in four months was 2.66 million euros, its products were sold to 30 countries in four continents.

According to unconsolidated preliminary results, sales of JSC Olainfarm in September 2016 were 6.47 million euro, which represents a reduction by 6% compared to the same period of 2015. The biggest sales increase was achieved in Kazakhstan, where sales grew by 227%. Sales to Tajikistan grew by 188%, but sales to Spain grew by 102%. Significant shipments during this period were also made to the UK and Denmark. Major sales markets of JSC Olainfarm during this period were Russia, Latvia, Ukraine, The Netherlands and Belarus. During September 2016 JSC Olainfarm sold its products in 26 countries in two continents.

September 2016, unconsolidated sales Sales, thsnd. EUR Changes to September 2015 Share in total sales
Russia 2 043 -10% 32%
Latvia 1 228 7% 19%
Ukraine 628 -47% 10%
The Netherlands 549 37% 8%
Belarus 544 11% 8%
Kazakhstan 391 227% 6%
UK 274 NA 4%
Spain 129 102% 2%
Denmark 119 NA 2%
Tajikistan 114 188% 2%
Other 451 -61% 7%
Total 6 470 -6% 100%

 

According to unconsolidated preliminary results, sales of JSC Olainfarm in nine months of 2016 were 66.07 million euros, which represents an increase by 3% compared to nine months of 2015. The biggest sales increase during this period was achieved in Uzbekistan, where sales grew by 72%. Sales to Turkmenistan grew by 38%, while sales to Ukraine grew by 37%. Majors sales markets in nine months of this year were Russia, Ukraine, Latvia and Belarus. In total during this period JSC Olainfarm sold its products to 39 countries in four continents.

9 months of 2016, unconsolidated sales Sales, thsnd. EUR Changes to 9 months of 2015 Share in total sales
Russia 22 587 -8% 34%
Ukraine 12 032 37% 18%
Latvia 9 916 8% 15%
Belarus 6 293 22% 10%
UK 1 815 19% 3%
Uzbekistan 1 780 72% 3%
Kazakhstan 1 727 -1% 3%
The Netherlands 1 639 -67% 2%
Turkmenistan 1 067 38% 2%
Lithuania 817 28% 1%
Other 6 401 10% 10%
Total 66 074 3% 100%

 

AGM of JSC Olainfarm held on June 7, this year approved operating plan of the Company and the Group, providing that Company’s sales in 2016 will reach 86 million euros, while Group’s sales will reach 100 million euros. According to these preliminary sales numbers, in nine months of 2016 seventy-seven percent of planned annual Company’s sales and 79% percent of planned annual Group’s sales have been attained.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

 

read more
Olainfarm’s Sales in September are 8.21 Million Euros

Olainfarm Named the Best Listed Company in Baltics

on 14 spalio, 2016 Komentavimas išjungtas įraše Olainfarm Named the Best Listed Company in Baltics

JSC Olainfarm was named the best listed company in the Baltics and has received “Baltic Corporate Excellence Award”. This is the first time Latvian company has received this Baltic award. Previous seven years award stayed in Lithuania. Last year the award winner was Lithuanian company Apranga. JSC Olainfarm was also named the best listed company in Latvia, an honour that Olainfarm has been awarded fifth year in a row. Olainfarm was appreciated this high for its ability to successfully operate despite unfavourable economic conditions in its main markets, and for its growth potential, backed by company’s diversification strategy in terms of geography, products and business segments.

Lithuanian clothing retailer Apranga was Baltic runner up this year and the best listed company in Lithuania. Estonian electrical engineering company Harju Elekter was named the best listed company of Estonia and the third best in the Baltics.

It is ninth consecutive years since Riga office of Swiss based analysts of CE Services in partnership with CE Asset Management AG and BA School of Business and Finance make comprehensive qualitative and quantitative analyses of companies listed on the official list of Nasdaq Baltic. The goal of the analyses is to identify the best company in Baltics depending on its historical financial indicators, competitiveness and quality of corporate governance. This year, the quality part of analysis was expanded by including factors of corporate social responsibility, as investors pay increasing attention to it.

Photo: Salvis Lapins, Member of the Management Board of JSC Olainfarm

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Olainfarm Named the Best Listed Company in Baltics

Notification of Olainfarm on Home Member State

on 29 rugsėjo, 2016 Komentavimas išjungtas įraše Notification of Olainfarm on Home Member State

Notification of AS Olainfarm on Home Member State

  1. Issuers Name: AS Olainfarm

Formerly known as AS Olaines Kimiski Farmaceitiska Rupnica

  1. Registered office: Rupnicu iela 8, Olaine, Latvia, LV 2114
  2. National company register number:  40003007246
  3. Home Member State: Latvia
  4. Triggering event: Issuer of shares admitted to trading
  5. Member State where the issuer’s securities are admitted to trading: 

                         

Shares            Debt securities                      Other securities

Latvia              14 850 780

  1. NCAs the form is required to be filed with: The Financial and Capital Market Commission, Latvia
  2. Date of notification: 29.09.2016
  3. Contact details:

Issuer`s address: Rupnicu iela 5, Olaine, Latvia, LV-2114
Person responsible within the issuer for the present notification: Salvis Lapins
E-mail address: Salvis.Lapins@olainfarm.lv
Telephone: +371 26448873

Dalibvalsts-EN

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Notification of Olainfarm on Home Member State

Sales of Olainfarm in August were 6.76 Million Euros

on 15 rugsėjo, 2016 Komentavimas išjungtas įraše Sales of Olainfarm in August were 6.76 Million Euros

Preliminary consolidated results of JSC Olainfarm for August 2016 show that sales of the company were 6.76 million euros, which represents an increase by 1% compared to the same period of 2015. The biggest sales increase was achieved in Czech Republic, where sales grew by 1866%. Sales to Ukraine grew by 182% while sales to Uzbekistan grew by 147%. During August 2016, JSC Olainfarm also made significant shipments to Brazil, and Germany. The major sales markets in August were Latvia, Russia, Ukraine and Belarus.

August 2016, consolidated sales Sales, thsnd. EUR Changes to August, 2015 Share in total sales
Latvia 2 179 33% 32%
Russia 1 366 -48% 20%
Ukraine 964 182% 14%
Belarus 495 -44% 7%
Uzbekistan 301 147% 4%
Czech Republic 250 1866% 4%
Kazakhstan 209 29% 3%
Brazil 120 NA 2%
Lithuania 80 -17% 1%
Germany 76 NA 1%
Other 720 -11% 11%
Total 6 760 1% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in August were 1.47 million euro, which represents an increase by 18% compared to the same period of last year. Sixty two pharmacies were operating during august 2016. Sales of  Silvanols Ltd. during August 2016 were 0.36 million euro, which represents an increase by 57% compared to August of 2015. Silvanols Ltd. was selling its products in six European countries and with the help of JSC Olainfarm also to Lithuania, Azerbaijan and Russia. Sales of Tonus Elast Ltd. during August 2016 were 0.76 million euros. The company sold its products to 23 countries in four continents.

According to preliminary consolidated numbers, the amount of sales of JSC Olainfarm in eight months of 2016 was 70.35 million euro, which represents an increase by 8% compared to eight months of 2015. The biggest sales increase was achieved in Uzbekistan, where sales grew by 112%. Sales to Poland increased by 75%, while sales to Ukraine increased by 51%. The major sales markets in eight months were Russia, Latvia, Ukraine and Belarus.

Eight months of 2016, consolidated sales Sales, thsnd. EUR Changes to eight months of 2015 Share in total sales
Russia 20 946 -6% 30%
Latvia 16 436 13% 23%
Ukraine 11 488 51% 16%
Belarus 5 771 23% 8%
Uzbekistan 1 751 112% 2%
UK 1 589 4% 2%
Kazakhstan 1 568 -4% 2%
The Netherlands 1 090 -76% 2%
Turkmenistan 1 067 38% 2%
Poland 992 75% 1%
Other 7 647 31% 11%
Total 70 345 8% 100%

 

Sales of pharmacy chain of Latvijas aptieka Ltd. in eight months was 12.3 million euros, which is an increase by 14% compared to eight months of 2015. Sales of Silvanols Ltd. in eight months of 2016 were 3.1 million euros, which represents an increase by 29%, as last year during this period sales of Silvanols Ltd. were 2.4 million euros. Products of Silvanols Ltd. during this period were sold to eleven European countries and with a help of JSC Olainfarm also to Albania, Kosovo, Azerbaijan, Kazakhstan, Belarus and Russia. Sales of Tonus Elast Ltd. in three months was 2.1 million euros. Its products were sold to 28 countries in four continents.

According to preliminary unconsolidated data, sales of JSC Olainfarm during August 2016 were 4.94 million euros, which represents a reduction by 16% compared to sales made during August of 2015. The biggest sales increase was achieved in Ukraine, where sales grew by 182%, while sales to Uzbekistan grew by 147%. Major sales markets of JSC Olainfarm during August 2016 were Russia, Latvia, Ukraine and Belarus. During August 2016, products of JSC Olainfarm were sold to 25 countries in three continents.

August, 2016, consolidates sales Sales, thsnd. EUR Changes to August 2015 Share in total sales
Russia 1 366 -48% 28%
Latvia 1 094 21% 22%
Ukraine 964 182% 20%
Belarus 483 -45% 10%
Uzbekistan 301 147% 6%
Kazakhstan 121 -26% 2%
Brazil 120 NA 2%
Lithuania 79 -10% 2%
Germany 73 NA 1%
Bulgaria 62 NA 1%
Other 274 -63% 6%
Total 4 937 -16% 100%

 

According to unconsolidated preliminary numbers, sales of JSC Olainfarm in eight months of 2016 were 59.65 million euros, which represents an increase by 4% compared to the same period of 2015. The biggest sales increase during this period was achieved in Uzbekistan, where sales grew by 112%. Sales to Ukraine grew by 50%, and sales to Lithuania grew by 44%. Major sales markets of JSC Olainfarm during this period were Russia, Ukraine, Latvia and Belarus. In total, during this eight months period products of JSC Olainfarm were sold to 38 countries in four continents.

Wight months of 2016, unconsolidated sales Sales, thsnd. EUR Changes to eight months of 2015 Share in total sales
Russia 20 545 -8% 34%
Ukraine 11 404 50% 19%
Latvia 8 739 9% 15%
Belarus 5 748 23% 10%
Uzbekistan 1 751 112% 3%
UK 1 540 1% 3%
Kazakhstan 1 336 -18% 2%
The Netherlands 1 090 -76% 2%
Turkmenistan 1 067 38% 2%
Lithuania 742 44% 1%
Other 5 692 17% 10%
Total 59 654 4% 100%

 

AGM of AS Olainfarm held on June 7, this year approved operating plan of the Company and the Group, providing that Company’s sales in 2016 will reach 86 million euros, while Group’s sales will reach 100 million euros. According to these preliminary sales numbers, in eight months of 2016 sixty nine percent of planned annual Company’s sales and 70% percent of planned annual Group’s sales have been attained.

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 211
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Sales of Olainfarm in August were 6.76 Million Euros

Recording of the Second Quarter 2016 Investor Conference Webinar

on 13 rugsėjo, 2016 Komentavimas išjungtas įraše Recording of the Second Quarter 2016 Investor Conference Webinar

On September 12 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of second quarter 2016 and informed about other recent activities within the company.

The recorded Olainfarm webinar is available online: http://ej.uz/OLF_Q2_2016_rec, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement: http://ej.uz/OLF_Q2_2016_PDF.

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

 

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Recording of the Second Quarter 2016 Investor Conference Webinar

Olainfarm holds Second Quarter 2016 Investor Conference Webinar

on 12 rugsėjo, 2016 Komentavimas išjungtas įraše Olainfarm holds Second Quarter 2016 Investor Conference Webinar

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 12, 2016 at 16:00 (EEST). Please note that attendees have to register for the webinar in advance – detailed information on the registration process is available below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm activities and financial results of second quarter of 2016. After the presentation investors are welcome to ask questions. During the webinar the enclosed presentation will be presented: Webinar Presentation: 2nd quarter and 6 months of 2016

To follow the webinar, you will need a computer with an internet connection and headphones. To join the webinar, you need to register in advance via http://ej.uz/OLF_Q2_2016.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.

A corporate webinar is a virtual conference, during which a company’s representative provides information about the company, its activities and future plans. A webinar provides an opportunity to receive information directly from the company while being located anywhere, as well as to receive answers to questions of interest to you. For more information on webinar service please visit: www.nasdaqbaltic.com/en/products-services/webinars-3/.

Join the webinar and be the first one to hear the news!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Olainfarm holds Second Quarter 2016 Investor Conference Webinar

Meet Olainfarm at the CPhI 2016 in Barcelona at Hall 5 Stand 5J18

on 9 rugsėjo, 2016 Komentavimas išjungtas įraše Meet Olainfarm at the CPhI 2016 in Barcelona at Hall 5 Stand 5J18

We are pleased to invite you to visit our stand 5J18 at Hall 5 at the CPhI 2016 in Barcelona, between 4th&6th October 2016.

Olainfarm will be on site showcasing our portfolio of FDFs, APIs and intermediates. We offer complete contract manufacturing services including research, scale-up, pilot and commercial manufacturing, as well as support with QC and validation. Our top level management will be available to discuss business with you straight away. If you are interested in setting up a meeting, please contact us stating your topic of interest, and we will reserve a timeslot for you at your preferred day and time.

Olainfarm is the leading manufacturer in the chemical and pharmaceutical sector of the Baltic States with more than 40 years of experience and export to more than 40 countries worldwide. Our key areas of specialization in FDFs include neurology, cardiology, infectology and allergology. We have a long-standing technological and know-how advantage in adamantane chemistry, quinuclidine chemistry, nitrofurane chemistry and optically pure g-aminobutyric acid derivatives, as well as in chiral compounds.

If you require any assistance or further information, please feel free to contact us:
Sigita Zviedre
Head of PR
Mobile: +371 26377286
E-mail: slapsina@olainfarm.lv

read more
Meet Olainfarm at the CPhI 2016 in Barcelona at Hall 5 Stand 5J18

Olainfarm will hold Second Quarter 2016 Investor Conference Webinar

on 8 rugsėjo, 2016 Komentavimas išjungtas įraše Olainfarm will hold Second Quarter 2016 Investor Conference Webinar

JSC Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference webinar scheduled on September 12, 2016 at 16:00 (EEST). Please note that attendees have to register for the webinar in advance – detailed information on the registration process is available below.

Webinar will be hosted by the Member of the Management Board Salvis Lapiņš. The presentation will be held in English.

During the webinar Salvis Lapiņš will inform about JSC Olainfarm activities and financial results of second quarter of 2016.

After the presentation investors are welcome to ask questions. Due to the limited webinar time, please send in your questions in advance till September 11 to e-mail: ieva.unda@nasdaq.com.

To follow the webinar, you will need a computer with an internet connection and headphones. To join the webinar, you need to register in advance via http://ej.uz/OLF_Q2_2016.

You will be provided with the webinar link and instructions to join webinar successfully. When joining the webinar for the first time, you will be asked to download the system application on your computer which will take only few seconds.

A corporate webinar is a virtual conference, during which a company’s representative provides information about the company, its activities and future plans. A webinar provides an opportunity to receive information directly from the company while being located anywhere, as well as to receive answers to questions of interest to you. For more information on webinar service please visit: www.nasdaqbaltic.com/en/products-services/webinars-3/.

Join the webinar and be the first one to hear the news!

 

JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 40 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.

Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: Salvis.Lapins@olainfarm.lv

read more
Olainfarm will hold Second Quarter 2016 Investor Conference Webinar

Search

Recent Posts